Summary
UnitedHealth Group Inc. (UNH) filed an 8-K on June 11, 2021, detailing the results of its 2021 Annual Meeting of Shareholders held on June 7, 2021. The report indicates overwhelming support for the election of all nine director nominees, with substantial majorities voting in favor of each. Additionally, the company's executive compensation was approved by a non-binding advisory vote, demonstrating shareholder confidence in the company's compensation structure. The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021, was also ratified by a significant majority. Furthermore, shareholders approved an amendment to the UnitedHealth Group 1993 Employee Stock Purchase Plan. However, a shareholder proposal seeking to reduce the share ownership threshold for calling a special meeting of shareholders was not approved. Overall, the meeting results reflect strong shareholder alignment with the company's governance and strategic direction, with the exception of the failed special meeting proposal.
Key Highlights
- 1All nine director nominees were overwhelmingly elected for a one-year term.
- 2Shareholders provided strong support for the company's executive compensation plan via a non-binding advisory vote.
- 3The appointment of Deloitte & Touche LLP as the independent auditor for fiscal year 2021 was ratified with substantial approval.
- 4An amendment to the UnitedHealth Group 1993 Employee Stock Purchase Plan received shareholder approval.
- 5A shareholder proposal to lower the threshold for calling a special meeting was not approved by shareholders.
- 6A significant portion of shares (853,588,552) were represented at the Annual Meeting.